CCR9 and COVID-19: We discovered several chemokine receptor signatures on NK cells (N = 8) associated with the development of severe COVID-19, including upregulated CX3CR1 expression on early NK cells (Fig. 3a) and increased levels of CCR4, CCR9 and CXCR3 on terminal NK cells (Fig. 3b).